Business Description
Rznomics Inc. is a South Korean biotechnology company founded in 2017 and based in Seongnam-si, focused on developing RNA-based treatments for cancer and serious diseases that currently have few effective options. The company has several programs at various stages of development, targeting conditions such as liver cancer, brain tumors, Alzheimer's disease, a degenerative eye condition called Retinitis Pigmentosa, and Rett Syndrome, a rare neurological disorder.
